| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Cardio-oncology/onco-cardiology Hong RA; Iimura T; Sumida KN; Eager RMClin Cardiol  2010[Dec]; 33 (12): 733-7An understanding of onco-cardiology or cardio-oncology is critical for the  effective care of cancer patients. Virtually all antineoplastic agents are  associated with cardiotoxicity, which can be divided into 5 categories: direct  cytotoxic effects of chemotherapy and associated cardiac systolic dysfunction,  cardiac ischemia, arrhythmias, pericarditis, and chemotherapy-induced  repolarization abnormalities. Radiation therapy can also lead to coronary artery  disease and fibrotic changes to the valves, pericardium, and myocardium. All  patients being considered for chemotherapy, especially those who have prior  cardiac history, should undergo detailed cardiovascular evaluation to optimize  the treatment. Serial assessment of left ventricular systolic function and  cardiac biomarkers might also be considered in selected patient populations.  Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of  angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or  beta-blockers. Antiplatelet or anticoagulation therapy might be considered in  patients with a potential hypercoagulable state associated with chemotherapy or  cancer. Open dialogue between both cardiologists and oncologists will be required  for optimal patient care.|*Cardiology[MESH]|*Medical Oncology[MESH]|*Patient Care Team[MESH]|Anticoagulants/therapeutic use[MESH]|Antineoplastic Agents/*adverse effects[MESH]|Cardiovascular Agents/therapeutic use[MESH]|Cooperative Behavior[MESH]|Heart Diseases/chemically induced/diagnosis/*etiology/prevention & control[MESH]|Heart Function Tests[MESH]|Humans[MESH]|Predictive Value of Tests[MESH]|Radiation Injuries/diagnosis/*etiology/prevention & control[MESH]|Thrombophilia/*chemically induced/diagnosis/prevention & control[MESH]
 |